U.S Traders

Pharmaceutical distrubutor January 7, 2016 -- The U.S.

Food and Drug Administration today approved a new indication for the Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) to treat certain diabetic foot ulcers. The matrix device, which is made of silicone, cow collagen, and shark cartilage, is placed over the ulcer and provides an environment for new skin and tissue to regenerate and heal the wound. An estimated 29 million people in the United States have been diagnosed with diabetes, according to the Centers...